| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C0010194> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C0022709> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C0035222> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C0748355> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C0852283> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C0960880> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C1449680> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C1563745> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33342421_HAS_TOPIC_C5392184>
?:authorAffiliation	[\'Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Mehan_Sidharth> <https://research.tib.eu/covid-19/entity/Sharma_Tarun>
?:doi	<https://research.tib.eu/covid-19/entity/10.2174/1871526520666201218153554>
?:doi	10.2174/1871526520666201218153554
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Infectious disorders drug targets
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33342421>
?:pmid	<https://research.tib.eu/covid-19/entity/33342421>
?:pmid	33342421
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0010194_DISRUPTS_C0042774> <https://research.tib.eu/covid-19/entity/C0010194_TREATS_C0035222> <https://research.tib.eu/covid-19/entity/C0024109_LOCATION_OF_C0006100> <https://research.tib.eu/covid-19/entity/C0302908_CAUSES_C0035222>
?:title	Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R Blocker.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33342421>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33342421>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all